menu search

FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label

FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
Sets PDUFA goal date of January 24, 2024 If approved, YUTREPIA would be indicated for treatment of both PAH and PH-ILD MORRISVILLE, N.C., Sept. 25, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (the Company) (NASDAQ: LQDA) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the Company’s amendment to the tentatively approved […] The post FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label appeared first on ForexTV... Read More
Posted: Sep 25 2023, 20:09
Author Name: forextv
Views: 090918

Search within

Pages Search Results: